Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis
Diseases of the Kidney & Urinary Tract
What is the purpose of this trial?
Evaluate the effect of Hectorol® capsules in reducing elevated levels of intact parathyroid hormone (iPTH).
- Evaluate the safety profile of Hectorol® capsules versus Rocaltrol® (calcitriol) capsules.
- Determine the pharmacokinetic profile of 1,25-dihydroxyvitamin D2 after administration of Hectorol®.
- Ages5 - 18 years
- Trial withSanofi-Aventis
- Start Date04/25/2019
- End Date12/26/2019
- Last Updated04/29/2019
- Study HIC#2000022264